Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Werge

Showing results (21-30 of 362) with videos related to

Pageof 37
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 29, 2005
Serotonin transporter: evolution and impact of polymorphic transcriptional regulationKaren Søeby, Svend A Larsen, Line Olsen, et al.
Basic & Clinical Pharmacology & Toxicology|June 5, 2013
Does pharmacogenetic testing for CYP450 2D6 and 2C19 among patients with diagnoses within the schizophrenic spectrum reduce treatment costs?Louise Herbild, Stig E Andersen, Thomas Werge, et al.
Biological Psychiatry|August 27, 2018
Can Animal Models of Copy Number Variants That Predispose to Schizophrenia Elucidate Underlying Biology?Annika Forsingdal, Trine Nygaard Jørgensen, Line Olsen, et al.
Frontiers in Genetics|July 28, 2020
Impute.me: An Open-Source, Non-profit Tool for Using Data From Direct-to-Consumer Genetic Testing to Calculate and Interpret Polygenic Risk ScoresLasse Folkersen, Oliver Pain, Andrés Ingason, et al.
Journal of Personalized Medicine|October 27, 2022
Is the CYP2D6 Genotype Associated with Antipsychotic-Induced Weight Gain?Gesche Jürgens, Benjamin Skov Kaas-Hansen, Merete Nordentoft, et al.
Current Protocols|December 5, 2022
Accurate and Effective Detection of Recurrent Copy Number Variants in Large SNP Genotype DatasetsSimone Montalbano, Xabier Calle Sánchez, Morteza Vaez, et al.
Scandinavian Journal of Public Health|January 25, 2011
Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services?Louise Herbild, Mickael Bech, Dorte Gyrd-Hansen, et al.
Pharmacology, Biochemistry, and Behavior|April 22, 2004
Effects of postnatal anoxia on striatal dopamine metabolism and prepulse inhibition in ratsKarin Sandager-Nielsen, Maibritt B Andersen, Thomas N Sager, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 22, 2009
No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatmentJens Drachmann Bukh, Camilla Bock, Maj Vinberg, et al.
Psychiatric Genetics|May 21, 2009
Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophreniaChristophe Butticaz, Thomas Werge, Jacques S Beckmann, et al.
Pageof 37

Showing results (21-30 of 362) with videos related to

Sort By:
Pageof 37
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 29, 2005
Serotonin transporter: evolution and impact of polymorphic transcriptional regulationKaren Søeby, Svend A Larsen, Line Olsen, et al.
Basic & Clinical Pharmacology & Toxicology|June 5, 2013
Does pharmacogenetic testing for CYP450 2D6 and 2C19 among patients with diagnoses within the schizophrenic spectrum reduce treatment costs?Louise Herbild, Stig E Andersen, Thomas Werge, et al.
Biological Psychiatry|August 27, 2018
Can Animal Models of Copy Number Variants That Predispose to Schizophrenia Elucidate Underlying Biology?Annika Forsingdal, Trine Nygaard Jørgensen, Line Olsen, et al.
Frontiers in Genetics|July 28, 2020
Impute.me: An Open-Source, Non-profit Tool for Using Data From Direct-to-Consumer Genetic Testing to Calculate and Interpret Polygenic Risk ScoresLasse Folkersen, Oliver Pain, Andrés Ingason, et al.
Journal of Personalized Medicine|October 27, 2022
Is the CYP2D6 Genotype Associated with Antipsychotic-Induced Weight Gain?Gesche Jürgens, Benjamin Skov Kaas-Hansen, Merete Nordentoft, et al.
Current Protocols|December 5, 2022
Accurate and Effective Detection of Recurrent Copy Number Variants in Large SNP Genotype DatasetsSimone Montalbano, Xabier Calle Sánchez, Morteza Vaez, et al.
Scandinavian Journal of Public Health|January 25, 2011
Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services?Louise Herbild, Mickael Bech, Dorte Gyrd-Hansen, et al.
Pharmacology, Biochemistry, and Behavior|April 22, 2004
Effects of postnatal anoxia on striatal dopamine metabolism and prepulse inhibition in ratsKarin Sandager-Nielsen, Maibritt B Andersen, Thomas N Sager, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 22, 2009
No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatmentJens Drachmann Bukh, Camilla Bock, Maj Vinberg, et al.
Psychiatric Genetics|May 21, 2009
Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophreniaChristophe Butticaz, Thomas Werge, Jacques S Beckmann, et al.
Pageof 37